Coagulation Analyzer Market Size, Overview, Key Players and Forecast 2025

The report “Hemostasis/Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. Coagulation analyzers and consumables are used to evaluate the coagulation profiles of blood samples, which are utilized for clotting-based or chromogenic assays and for diagnosing clotting factor deficiencies. They are primarily used in wound, injury, and pre- and post-operative management.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392

The growth of the global coagulation analyzers market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population. Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.

Prothrombin time tests accounted for the largest market share

In 2019, the prothrombin time testing segment accounted for the largest share of the coagulation analyzers market. Growth in this market segment can be attributed to the high usage of prothrombin time tests in measuring the time it takes for blood to clot. These tests are used to monitor patients implanted with mechanical heart valves, ventricular assist devices, chronic atrial fibrillation, venous embolism and thrombosis of deep vessels of lower extremities, deep venous thrombosis, and pulmonary embolism.

Clinical laboratory analyzers dominated the coagulation analyzers market in 2019

Based on product, the coagulation analyzers market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2019, the clinical laboratory analyzers segment accounted for a larger share of the coagulation analyzers market. The large share of this segment can be attributed to factors such as the growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities.

Optical technology segment accounted for the largest share of the coagulation analysers market, by technology, in 2019

The coagulation analysers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analysers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thermoelectrometry technologies. The most widely used technology in the coagulation analyzers market is the optical technology. This segment accounted for the largest share of the market in 2019.

Clinical laboratories dominated the coagulation analysers market in 2019

On the basis of end user, the coagulation analysers market is segmented into clinical laboratories, hospitals, and other end users. In 2019, the clinical laboratories segment accounted for the largest share of the coagulation analysers market.

North America is the largest regional market for coagulation analysers

North America (comprising the US and Canada) accounted for the largest share of the global coagulation analyzers market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the coagulation analyzers market in North America.

Inquiry Before Buying @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392

Key Player

The major players operating in the coagulation analyzers market are Abbott Laboratories (US), Danaher (US), Siemens Healthineers Group (Germany), Sysmex Group (US), Thermo Fisher Scientific (US), Horiba (Japan), Nihon Kohden (Japan), Roche Diagnostics (Switzerland), Maccura Biotechnology Co. Ltd. (China), Bio Group Medical System (Italy), Genrui Biotech Inc. (China),  A&T Corporation (Japan), Beijing Succeeder Technology Inc. (China), Diagnostica Stago SAS (France),  Helena Laboratories (US), Hycel (Austria), Eurolyser (Austria), Bpc Biosed Srl (Italy), Robimes India Pvt. Ltd (India), Meril Life Sciences (India), ERBA Diagnostics, Inc. (US), Sclavo Diagnostics International S.r.l (Italy), Haematonics (US), Biosystems S.A. (Spain), and ACON (US).

Asia Pacific market to grow at the highest rate from 2020 to 2025

The coagulation analyzers market in the Asia Pacific is expected to grow at a high CAGR in the coming years. The factors contributing to the high growth of this market include the rising incidence/prevalence of blood-related disorders, increasing government initiatives for the improvement of healthcare infrastructure, rising number of general surgeries, and growth in research activities in several Asia Pacific countries. Moreover, the rapidly growing geriatric population (and the subsequent increase in the incidence of thalassemia, sickle-cell anemia, and leukemia) and healthcare infrastructure improvements in countries such as Japan, China, and Australia are expected to support the growth of this market in the coming years.

View detailed Table of Content here@

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=197226392

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are moulded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit MarketsandMarkets™ or follow us on Twitter, LinkedIn and Facebook.